Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$801K Buy
33,268
+212
+0.6% +$5.55K 0.02% 210
2026
Q1
$928K Buy
+33,056
New +$880K 0.03% 199
2025
Q2
$614K Sell
25,337
-695
-3% -$16.2K 0.03% 208
2025
Q1
$660K Sell
26,032
-715
-3% -$18.7K 0.03% 201
2024
Q4
$710K Sell
26,747
-17,417
-39% -$472K 0.04% 186
2024
Q3
$1.28M Buy
44,164
+2,695
+6% +$78.6K 0.07% 120
2024
Q2
$1.16M Buy
41,469
+3,683
+10% +$101K 0.06% 114
2024
Q1
$1.05M Buy
37,786
+23,864
+171% +$662K 0.06% 110
2023
Q4
$401K Buy
13,922
+2,514
+22% +$76K 0.03% 198
2023
Q3
$378K Sell
11,408
-421
-4% -$14.9K 0.03% 175
2023
Q2
$434K Sell
11,829
-1,075
-8% -$41.8K 0.03% 143
2023
Q1
$526K Sell
12,904
-35
-0.3% -$1.51K 0.04% 121
2022
Q4
$663K Sell
12,939
-1,152
-8% -$55.2K 0.06% 110
2022
Q3
$617K Buy
14,091
+972
+7% +$47.2K 0.06% 112
2022
Q2
$688K Buy
13,119
+32
+0.2% +$1.63K 0.06% 112
2022
Q1
$678K Sell
13,087
-1,617
-11% -$83.9K 0.02% 105
2021
Q4
$868K Sell
14,704
-459
-3% -$22.7K 0.03% 119
2021
Q3
$652K Buy
+15,163
New +$672K 0.03% 117
2021
Q1
$456K Buy
+12,587
New +$447K 0.04% 142

Other funds holding PFE

E Fund Management's PFE Position: Q2 2026 in Review

E Fund Management increased its Pfizer (PFE) stake by 0.64% in Q2 2026, buying an estimated $5.55K and bringing the position to 33,268 shares worth $801K. The position accounts for 0.02% of the portfolio, ranked #210.

E Fund Management first reported a position in PFE in Q1 2021 and has held it in 19 quarters since. The position peaked at $1.28M in Q3 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • E Fund Management held 33,268 shares of Pfizer worth $801K as of Q2 2026.
  • E Fund Management bought 212 Pfizer shares in Q2 2026, an estimated $5.55K.
  • Pfizer made up 0.02% of E Fund Management's portfolio in Q2 2026, its #210 holding.
  • E Fund Management first reported a position in Pfizer in Q1 2021 and has held it in 19 quarters since.
  • E Fund Management's Pfizer position peaked at $1.28M in Q3 2024.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.